title: Re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035: Corticosteroid-associated Adverse Events in Elderly Patients.
authors.affiliation: Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy; Unit of Molecular Therapy and Pharmacogenomics, AO Azienda Istituti Ospitalieri di Cremona, Cremona, Italy. Electronic address: giandomenicoroviello@gmail.com.
authors.forename: Giandomenico
authors.initials: G
authors.lastname: Roviello
authors.affiliation: Unit of Molecular Therapy and Pharmacogenomics, AO Azienda Istituti Ospitalieri di Cremona, Cremona, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Bottini
authors.affiliation: Unit of Molecular Therapy and Pharmacogenomics, AO Azienda Istituti Ospitalieri di Cremona, Cremona, Italy; Department of Medical, Surgery, and Health Sciences, University of Trieste, Piazza Ospitale, Trieste, Italy.
authors.forename: Daniele
authors.initials: D
authors.lastname: Generali
mesh_terms: D000069501:Abiraterone Acetate; D000305:Adrenal Cortex Hormones; D000368:Aged; D006801:Humans; D015994:Incidence; D008297:Male; D011241:Prednisone; D064129:Prostatic Neoplasms, Castration-Resistant
chemical_list: D000305:Adrenal Cortex Hormones; D000069501:Abiraterone Acetate; D011241:Prednisone